Aequus Pharmaceuticals Inc.
AQSZF
$0.004
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -188.88% | 65.48% | 9.72% | -1.65% | 6.67% |
| Total Depreciation and Amortization | -2.12% | -2.88% | 0.41% | -1.22% | -1.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14,250.00% | -114.55% | -29.79% | 37.43% | 14.00% |
| Change in Net Operating Assets | 40.34% | -49.71% | 339.22% | -203.20% | 135.33% |
| Cash from Operations | 138.91% | 77.79% | 50.45% | -33.33% | 41.64% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -72.68% | -32.38% | -13.44% | -36.46% |
| Total Debt Repaid | -1.42% | -0.72% | 0.00% | 0.00% | -5.54% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -170.12% | -82.44% | -34.82% | -15.65% | -37.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -143.50% | 229.20% | 90.53% | -144.84% | -238.08% |